Subscribe to our newsletter to receive the latest product updates and special offers

Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

NEW: Revenue Breakdown and Options Chain

Gain deeper insights into company revenues with a detailed analysis of revenue sources.
Explore the updated Options feature, providing in-depth data, and a 3D viewing option.

Last Close
Apr 23 04:00PM ET
Dollar change
Percentage change
Index- P/E- EPS (ttm)-13.46 Insider Own0.07% Shs Outstand6.80M Perf Week-11.52%
Market Cap2.02M Forward P/E- EPS next Y-1.48 Insider Trans0.00% Shs Float6.80M Perf Month-32.17%
Income-22.63M PEG- EPS next Q-0.94 Inst Own3.13% Short Float12.08% Perf Quarter-48.90%
Sales8.86M P/S0.23 EPS this Y76.69% Inst Trans1.35% Short Ratio1.18 Perf Half Y-73.89%
Book/sh0.53 P/B0.56 EPS next Y44.88% ROA-117.35% Short Interest0.82M Perf Year-93.07%
Cash/sh0.56 P/C0.53 EPS next 5Y- ROE-263.36% 52W Range0.24 - 5.73 Perf YTD-48.98%
Dividend Est.- P/FCF- EPS past 5Y84.44% ROI-602.58% 52W High-94.83% Beta0.14
Dividend TTM- Quick Ratio1.96 Sales past 5Y12.67% Gross Margin56.22% 52W Low23.50% ATR (14)0.05
Dividend Ex-Date- Current Ratio2.59 EPS Y/Y TTM89.22% Oper. Margin-198.89% RSI (14)37.69 Volatility25.28% 12.39%
Employees59 Debt/Eq0.33 Sales Y/Y TTM3.76% Profit Margin-255.27% Recom2.00 Target Price1.50
Option/ShortNo / No LT Debt/Eq0.26 EPS Q/Q55.23% Payout- Rel Volume10.35 Prev Close0.33
Sales Surprise-0.65% EPS Surprise-61.15% Sales Q/Q9.06% EarningsMar 05 BMO Avg Volume697.69K Price0.30
SMA20-18.13% SMA50-35.03% SMA200-70.85% Trades Volume7,221,379 Change-11.26%
Apr-09-24 09:00AM
Mar-07-24 09:08AM
Mar-05-24 08:00AM
Feb-27-24 09:00AM
Feb-22-24 07:58AM
05:06PM Loading…
Feb-20-24 05:06PM
Feb-06-24 09:00AM
Jan-04-24 03:05PM
Nov-28-23 08:00AM
Nov-14-23 04:30PM
Nov-08-23 01:08PM
Nov-07-23 08:00AM
Nov-01-23 08:00AM
Oct-31-23 08:00AM
04:15PM Loading…
Oct-18-23 04:15PM
Oct-17-23 04:15PM
Oct-13-23 08:30AM
Oct-10-23 08:00AM
Sep-11-23 04:15PM
Aug-08-23 08:15AM
Jul-18-23 04:15PM
Jun-20-23 08:30AM
Jun-13-23 04:15PM
Jun-05-23 04:15PM
May-22-23 05:10PM
May-09-23 08:00AM
Apr-18-23 08:00AM
Mar-21-23 08:00AM
08:00AM Loading…
Mar-01-23 08:00AM
Feb-28-23 08:00AM
Feb-23-23 04:15PM
Feb-07-23 08:00AM
Jan-09-23 08:00AM
Jan-05-23 02:40PM
Jan-04-23 05:25PM
Dec-29-22 01:35PM
Dec-27-22 04:45PM
Dec-13-22 08:00AM
Dec-08-22 08:10AM
Nov-30-22 08:00AM
Nov-18-22 05:00PM
Nov-08-22 08:00AM
Nov-03-22 07:00AM
Oct-19-22 04:15PM
Oct-18-22 04:15PM
Oct-14-22 08:30AM
Oct-03-22 07:00AM
Sep-27-22 07:00AM
Aug-31-22 07:00AM
Aug-25-22 07:00AM
Aug-19-22 03:00PM
Aug-09-22 08:00AM
Jul-26-22 07:00AM
Jul-14-22 08:00AM
Jul-12-22 07:00AM
Jun-29-22 07:00AM
Jun-14-22 07:00AM
May-17-22 04:25PM
May-10-22 08:00AM
May-09-22 01:11PM
Apr-12-22 08:00AM
Mar-15-22 07:00AM
Mar-01-22 08:00AM
Feb-22-22 05:15PM
Feb-17-22 08:00AM
Feb-01-22 08:00AM
Jan-25-22 08:00AM
Nov-19-21 04:00PM
Nov-09-21 08:00AM
Nov-04-21 08:00AM
Oct-19-21 08:00AM
Oct-14-21 04:03PM
Sep-21-21 08:00AM
Sep-17-21 04:00PM
Sep-15-21 08:19AM
Sep-14-21 04:03PM
Aug-31-21 07:00AM
Aug-24-21 09:00AM
Aug-10-21 08:00AM
Aug-05-21 08:00AM
Jul-27-21 04:03PM
Jul-13-21 08:00AM
Jul-06-21 04:03PM
Jul-01-21 04:00PM
Jun-24-21 08:00AM
Jun-22-21 08:00AM
Jun-01-21 08:00AM
May-20-21 04:03PM
May-17-21 08:00AM
May-13-21 08:45AM
May-11-21 08:00AM
Apr-29-21 04:05PM
Nuwellis, Inc. operates as a medical device company. It engages in the provision of products for the treatment of fluid overload. The firm's products include Aquadex FlexFlow System, which provides an ultrafiltration for the removal of salt and water in patients with hypervolemia, or fluid overload. It operates through Cardiac and Coronary Disease Products segment. The company was founded by Crispin Marsh and William S. Peters in November 1999 and is headquartered in Eden Prairie, MN.